Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 13, 2003
Diastereoselective solution and multipin-based combinatorial array synthesis of a novel class of potent phosphinic metalloprotease inhibitorsAnastasios Makaritis, Dimitris Georgiadis, Vincent Dive, et al.Organic Letters|September 25, 2009
A modular rearrangement approach toward medicinally relevant phosphinic structuresVassilis Rogakos, Dimitris Georgiadis, Vincent Dive, et al.ACS Omega|October 10, 2022
Design, Synthesis, and Study of a Novel RXPA380-Proline Hybrid (RXPA380-P) as an Antihypertensive AgentMoaz M Abdou, Dewen Dong, Paul M O'Neill, et al.Plos One|April 4, 2018
Functional examination of novel kisspeptin phosphinic peptidesXiaoyang Zhang, Magdalini Matziari, Yixin Xie, et al.Biochemistry|June 24, 2004
Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domainDimitris Georgiadis, Philippe Cuniasse, Jöel Cotton, et al.Current Pharmaceutical Design|November 21, 2009
Inhibition of zinc metallopeptidases in cardiovascular disease--from unity to trinity, or duality?Vincent Dive, Cheng-Fu Chang, Athanasios Yiotakis, et al.ACS Omega|January 1, 2026
Highly Potent Phosphinic HIV‑1 Protease Inhibitors: Synthesis, In Vitro Evaluation, and Docking StudiesKomal Hayat, Danwen Qiu, Yuanyuan Wang, et al.The FEBS Journal|April 21, 2006
Combined use of selective inhibitors and fluorogenic substrates to study the specificity of somatic wild-type angiotensin-converting enzymeNicolas D Jullien, Philippe Cuniasse, Dimitris Georgiadis, et al.Journal of Medicinal Chemistry|November 11, 2009
Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitorsNicolas Jullien, Anastasios Makritis, Dimitris Georgiadis, et al.Circulation Research|June 14, 2003
Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitorsDimitris Georgiadis, Fabrice Beau, Bertrand Czarny, et al.Pageof 5